Correction: PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix
Oncotarget
.
2019 Jul 30;10(46):4802.
doi: 10.18632/oncotarget.27101.
Authors
Minakshi Mann
1
,
Sachin Kumar
1
,
Shyam S Chauhan
2
,
Neerja Bhatla
3
,
Sunesh Kumar
3
,
Sameer Bakhshi
1
,
Ritu Gupta
4
,
Ashok Sharma
2
,
Lalit Kumar
1
Affiliations
1
Department of Medical Oncology, Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.
2
Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India.
3
Department of Obstetrics and Gynecology, All India Institute of Medical Sciences, New Delhi, India.
4
Laboratory Oncology Unit, Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.
PMID:
31413820
PMCID:
PMC6677665
DOI:
10.18632/oncotarget.27101
Abstract
[This corrects the article DOI: 10.18632/oncotarget.27008.].
Publication types
Published Erratum